Related by context. Frequent words. (Click for all words.) 69 ranibizumab 64 plus methotrexate 63 FOLFIRI 62 plus prednisone 62 peginterferon alfa 2a 62 mg BID 61 placebo p = 61 peginterferon alfa 2b 61 HbA1c levels 61 active comparator 61 sustained virologic response 60 placebo p 60 dacarbazine 60 severe renal impairment 60 tamsulosin 60 azathioprine 59 placebo 59 PROMACTA 59 adalimumab 59 decitabine 59 febuxostat 59 discontinuations due 59 virologic failure 59 fluorouracil 59 visual acuity 59 #mg dose [003] 59 LVEF 59 mitoxantrone 59 annualized relapse 58 unfractionated heparin 58 plus ribavirin 58 mcg kg 58 FOLFOX 58 peg IFN 58 serum phosphorus 58 leukopenia 58 azacitidine 58 creatinine clearance 58 peginterferon 58 tocilizumab 57 pioglitazone 57 glimepiride 57 Torisel 57 prespecified 57 quetiapine 57 TORISEL 57 tiotropium 57 HbA1c 57 p = #.# [002] 57 abatacept 57 fondaparinux 57 noninferiority 57 vinorelbine 57 statistically significant p 56 epoetin alfa 56 raltegravir 56 confidence interval #.#-#.# 56 P = .# 56 esomeprazole 56 Taxotere ® 56 donepezil 56 nitazoxanide 56 subcutaneous injections 56 PegIntron 56 lamivudine 56 atazanavir 56 hypomagnesemia 56 interferon alfa 56 mg d 56 Secondary endpoints 56 composite endpoint 56 dose regimens 56 HCTZ 56 etanercept 56 antihypertensive medications 55 confidence interval CI 55 ziprasidone 55 laboratory abnormalities 55 mg dose 55 adefovir 55 events AEs 55 fingolimod 55 vandetanib 55 bosentan 55 certolizumab pegol 55 median PFS 55 ocrelizumab 55 bortezomib 55 ARCALYST 55 pemetrexed 55 metastatic renal cell carcinoma 55 darunavir 55 bevacizumab 55 enoxaparin 55 epoetin 55 Secondary endpoints included 55 pazopanib 55 mg doses 55 temsirolimus 55 discontinuations 55 IPSS